Clinical efficacy and safety of Ceftazidime Injection in children with bacterial lower respiratory infection
Juan Wu
Abstract
Juan Wu
Abstract
Objective:To evaluate the clinical efficacy and safety of Ceftazidime Injection in Children with bacterial lower respiratory infection.Methods:Cefoperazone/Sulbactam sodium(Sulperazon) as a control drug and 180 cases of children tested in randomized controlled trials.98 cases of the test group given Ceftazidime 60 mg/(kg·d) were intravenous infused twice, 82 cases of the control group given Sulperazon 50 mg/(kg·d) were intravenous injected twice, regimens for 7 days.Results:The efficiency of the test group and control group were 92.86% and 90.24%.The bacterial clearance rate of the test group was 88.24%, it was higher than the control group(85.94%).Adverse effect rate of the two groups were 7.14% and 7.32%, there was no significant difference(P0.05).Conclusion:Ceftazidime Injection has a good efficacy and safety for treatment of bacterial lower respiratory infection in children, there is a high clinical value.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To evaluate the clinical efficacy and safety of Ceftazidime Injection in Children with bacterial lower respiratory infection.Methods:Cefoperazone/Sulbactam sodium(Sulperazon) as a control drug and 180 cases of children tested in randomized controlled trials.98 cases of the test group given Ceftazidime 60 mg/(kg·d) were intravenous infused twice, 82 cases of the control group given Sulperazon 50 mg/(kg·d) were intravenous injected twice, regimens for 7 days.Results:The efficiency of the test group and control group were 92.86% and 90.24%.The bacterial clearance rate of the test group was 88.24%, it was higher than the control group(85.94%).Adverse effect rate of the two groups were 7.14% and 7.32%, there was no significant difference(P0.05).Conclusion:Ceftazidime Injection has a good efficacy and safety for treatment of bacterial lower respiratory infection in children, there is a high clinical value.
Key concepts: Medicine, Ceftazidime, Cefoperazone, Adverse effect, Anesthesia, Clinical efficacy, Respiratory system, Sulbactam